Ledger.Open graph →
SEC Form D · filed February 24, 2020

AVM BIOTECHNOLOGY, LLC

Offering
$14.7M
Sold
$2.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Theresa Deisher · Seattle, WAExec · DirectorCharles Pope · Tampa, FLExec · DirectorChristopher C. Price · London, United KingdomExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗